Is INFI a good stock to buy?
Out of 4 analysts, 3 (75%) are recommending INFI as a Strong Buy, 1 (25%) are recommending INFI as a Buy, 0 (0%) are recommending INFI as a Hold, 0 (0%) are recommending INFI as a Sell, and 0 (0%) are recommending INFI as a Strong Sell. What is INFI’s earnings growth forecast for 2022-2024?
Where is Infinity Pharmaceuticals located?
Cambridge, Massachusetts
Infinity Pharmaceuticals is located in Cambridge, Massachusetts, United States .
When did Infinity Pharmaceuticals go public?
July 2000
Infinity’s stock, which went public in July 2000 at an IPO price of $18, was trading around $1.55 ahead of the open; the previous all-time intraday low of $3.74 was hit in October 2008.
Will Infinity Pharmaceuticals go up?
The 7 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 11.00 and a low estimate of 3.00. The median estimate represents a +614.39% increase from the last price of 0.70.
What does Infinity Pharmaceutical do?
Infinity Pharmaceuticals, Inc. is an innovative biopharmaceutical company dedicated to discovering, developing and delivering best-in-class medicines to people with difficult-to-treat diseases.
What does savara Inc do?
Savara Inc. operates as a clinical-stage pharmaceutical company. The Company focuses on the development of novel therapies for the treatment of serious and life-threatening rare respiratory diseases.
Is savara a buy?
The 5 analysts offering 12-month price forecasts for Savara Inc have a median target of 3.00, with a high estimate of 7.00 and a low estimate of 2.00. The median estimate represents a +132.56% increase from the last price of 1.29.
What does the name savara mean?
Meaning of Savara: Name Savara in the Sanskrit origin, means The tone or the tunes, self shining. Name Savara is of Sanskrit origin and is a Girl name.
Will Svra stock go up?
Stock Price Forecast The 5 analysts offering 12-month price forecasts for Savara Inc have a median target of 3.00, with a high estimate of 7.00 and a low estimate of 2.00. The median estimate represents a +132.56% increase from the last price of 1.29.
Is SVRA a buy?
The 5 analysts offering 12-month price forecasts for Savara Inc have a median target of 3.00, with a high estimate of 7.00 and a low estimate of 2.00. The median estimate represents a +114.29% increase from the last price of 1.40.